Amends the litigation funding act to promote consumer protections related to litigation funding contracts; provides for contract requirements for litigation funding including disclosures, prohibitions; provides for litigation funding company registration and reporting requirements.
Impact
The proposed bill introduces mandatory disclosures that litigation funding contracts must include, such as the total charges, payment schedules, and a right of rescission allowing consumers to cancel contracts within a specified timeframe. It also prohibits litigation funding companies from imposing excessive charges that exceed 25% of the gross recovered amount and regulates the amount of funding provided to consumers, limiting it to $500,000. Such changes are intended to protect consumers from potentially exploitative lending practices and maintain fair standards in the industry.
Summary
A09442, introduced in the New York State Assembly, aims to amend the financial services law in relation to litigation funding. This bill is designed to enhance consumer protections associated with litigation funding contracts while establishing specific contract requirements, prohibitions, and regulations for litigation funding companies. By replacing previous legislative measures, the bill seeks to ensure that consumers entering into litigation funding agreements are well-informed about their rights and obligations.
Contention
Notable points of contention surrounding A09442 revolve around balancing consumer protection with the operational freedoms of litigation funding companies. Supporters argue that the enhanced disclosure and regulation are necessary to prevent consumer exploitation, while some industry representatives express concern that these restrictions could hinder access to funding for consumers pursuing legal claims. Moreover, the bill addresses issues of transparency and accountability within the litigation funding realm, which has sparked discussions among legal professionals and consumer advocacy groups.
Same As
Amends the litigation funding act to promote consumer protections related to litigation funding contracts; provides for contract requirements for litigation funding including disclosures, prohibitions; provides for litigation funding company registration and reporting requirements.
Amends the litigation funding act to promote consumer protections related to litigation funding contracts; provides for contract requirements for litigation funding including disclosures, prohibitions; provides for litigation funding company registration and reporting requirements.
Enacts the consumer litigation funding act to promote consumer protections related to consumer litigation funding transactions; provides for contract requirements, including that the contract contain a no penalty provision for the prepayment of the funded amount prior to the settlement of their case; makes related provisions.
Enacts the consumer litigation funding act to promote consumer protections related to consumer litigation funding transactions; provides for contract requirements, including that the contract contain a no penalty provision for the prepayment of the funded amount prior to the settlement of their case; makes related provisions.
Enacts the consumer litigation funding act to promote consumer protections related to consumer litigation funding transactions; provides for contract requirements, including that the contract contain a no penalty provision for the prepayment of the funded amount prior to the settlement of their case; makes related provisions.
Change the statute of limitations for personal injury actions, include administrative proceedings within the Nonrecourse Civil Litigation Act, require disclosures by consumers under such act, and provide for discipline against civil litigation funding companies
Discovery; creating the Foreign Litigation Funding Prevention Act; commercial litigation funding agreements; prohibiting admissibility of certain information as evidence; effective date.
Discovery; creating the Foreign Litigation Funding Prevention Act; commercial litigation funding agreements; prohibiting admissibility of certain information as evidence; effective date.